|
REFERENCIAS.
1. Baldini, Elizabeth Healey et al. "Patterns of Failure after Trimodality Therapy for Malignant Pleural Mesothelioma." Ann Thorac Surg. 1997; 63:334-8.
2. Sugarbaker, David J. et al. "Surgical Staging and Work-up of Patients with Diffuse Malignant Pleural Mesothelioma." Seminars in Thoracic and Cardiovascular Surgery. Vol 9, No 4 (October), 1997: pp 356-60.
3. Sugarbaker, D.J. et al. "Node Status Has Prognostic Significance in the Multimodality Therapy of Diffuse, Malignant Mesothelioma." Journal of Clinical Oncology. Vol 11, No 6 (June), 1993: pp 1172-1178.
4. Rusch, Valerie W. "Pleurectomy/decortication in the Setting of Multimodality Treatment for Diffuse Malignant Pleural Mesothelioma." Seminars in Thoracic and Cardiovascular Surgery. Vol 9, No 4 (October), 1997: pp 367-72.
5. Ong, S.T. & Vogelzang, N.J. "Chemotherapy in Malignant Pleural Mesothelioma: A Review." Journal of Clinical Oncology. Vol 14, No 3 (March), 1996: pp 1007-1017.
6. Kaiser, Larry R. "New Therapies in the Treatment of Malignant Pleural Mesothelioma." Seminars in Thoracic and Cardiovascular Surgery. Vol 9, No 4 (October), 1997: pp 383-90.
7. Ruffie P, Feld R, Minkin S, et al.: Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: a retrospective study of 332 patients. Journal of Clinical Oncology 7(8): 1157-1168, 1989.
8. Tammilehto L, Maasilta P, Kostiainen S, et al.: Diagnosis and prognostic factors in malignant pleural mesothelioma: a retrospective analysis of sixty-five patients. Respiration 59: 129-135, 1992.
9. M. Pistolesi and J. Rusthoven.Malignant Pleural Mesothelioma: Update, Current Management, and Newer Therapeutic Strategies
Chest, October 1, 2004; 126(4): 1318 - 1329.
10. W. Weder, P. Kestenholz, C. Taverna, S. Bodis, D. Lardinois, M. Jerman, and R. A. Stahel. Neoadjuvant Chemotherapy Followed by Extrapleural Pneumonectomy in Malignant Pleural Mesothelioma
J. Clin. Oncol., September 1, 2004; 22(17): 3451 - 3457.
|